Articles tagged "Renal function"

2017 American Transplant Congress
Urinary Concentration Ability in Kidney Transplant Patients as Predictor for CKD.
P. Garcia-Garcia,¹ A. Jarque,¹ A. Rivero,¹ A. Rodriguez,¹ J. Gonzalez Posadas,¹ M. Macia,¹ V. Garcia Nieto,² J. Navarro.¹
¹Nephrology Service, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; ²Pediatric Nephrology Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
Urinary concentration is the result of a complex glomerulotubular mechanism, which culpits with the stimulation of aquaporins at the collector tubule, in response to vasopressin…
2017 American Transplant Congress
Comparing Renal Function Recovery and Long Term Outcomes in Recipients of Standard and Expanded Criteria Donor Kidney Transplants.
S. Sandal, M. Cantarovich, S. Paraskevas, N. Almaghrawi, P. Chaudhury, J. Tchervenkov.
McGill University Health Center, Montreal, Canada
Several donor and recipient characteristics are associated with adverse kidney transplantation (KT) outcomes. Our group has previously shown that based on the donor's terminal creatinine,…
2017 American Transplant Congress
Risk Factors for Hospital Readmission with Urinary Tract Infections (UTIs) Following Kidney Transplantation (KT).
E. Minja, S. Jackson, A. Matas.
Surgery, UMN, Mpls, MN
UTIs are common causes of hospital readmissions after KT. Our objective is to determine predictors of hospital readmissions for UTI within 1 year after a…
2017 American Transplant Congress
Donation After Cardiac Death (DCD) Liver Transplantation (LT) Is Not Associated with Post-LT Renal Dysfunction.
H. Wadei, M. Mai, D. Lee, K. Croome, B. Rosser, A. Keaveny, B. Taner.
Transplant, Mayo Clinic, Jacksonville, FL
The relationship between DCD LT and post-LT renal dysfunction is unclear. Aim: Determine the effects of DCD LT compared to donation after brain death (DBD)…
2016 American Transplant Congress
Comparison of Transplant Outcomes for Low-Dose and Standard-Dose Tacrolimus in Kidney Transplant Recipients.
J.-H. Cho, K. Kim, M. Kim, W. Do, Y. Yang, T. Yim, I. Hwang, J.-H. Lee, E. Kwon, H.-Y. Jung, J.-Y. Choi, S.-H. Park, Y.-L. Kim, C.-D. Kim.
Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
Objectives: There are few studies that compare the effect of different dose of tacrolimus after kidney transplantation. We investigated transplant outcome of low-dose and standard-dose…
2016 American Transplant Congress
Evaluation of the Long-Term Outcomes with Everolimus After Calcineurin Inhibitor Withdrawal: 36M Results of the H2304 and PROTECT Extension Studies.
L. Fischer,^1,2 J. Fung,¹ H. Metselaar,¹ G. Kaiser,^1,2 P. Schemmer,² P. Neuhaus,² G. Dong,³ P. Lopez,⁴ P. Bernhardt,⁴ H. Schlitt.²
¹H2304 study group, Hamburg, Germany; ²PROTECT study group, Hamburg, Germany; ³Novartis Pharmaceuticals Corporation, East Hanover, NJ; ⁴Novartis Pharma AG, Basel, Switzerland.
Background: The H2304 and PROTECT studies demonstrated reduced nephrotoxicity with everolimus (EVR)-based calcineurin inhibitor (CNI; cyclosporine: CsA, tacrolimus: TAC)-free regimens at Month (M) 12. Here,…
2016 American Transplant Congress
TRANSFORM: A Modern Approach to Evaluate Long-Term Outcomes of Everolimus with Reduced-Calcineurin Inhibitors in De Novo Kidney Transplant Recipients[mdash]Baseline Characteristics.
M. Henry.
On behalf of the TRANSFORM Investigators, Division of Transplantation Surgery, Wexner Medical Center, The Ohio State University, Columbus, OH.
Purpose: Acute rejection and poor graft function are two major risk factors for allograft failure in kidney transplant (KTx) recipients (KTxR). Although, graft survival and…
2016 American Transplant Congress
Impact on Renal Function of Stepwise Withdrawal of Tacrolimus Combined with Everolimus and EC-MPS vs Standard Treatment Combining Tacrolimus and EC-MPS in De Novo Liver Transplant Recipients: Results of the SIMCER Study.
F. Saliba,¹ C. Duvoux,² S. Dharancy,³ J. Dumortier,⁴ Y. Calmus,⁵ F. Di Giambattista,⁶ F. Conti.⁵
¹Hôpital Paul Brousse, Villejuif, France; ²Hôpital Henri Mondor, Créteil, France; ³Hôpital Claude Huriez, Lille, France; ⁴Hôpital Edouard Herriot, Lyon, France; ⁵Hôpital La Pitié-Salpêtrière, Paris, France; ⁶Novartis Pharma SAS, Rueil-Malmaison, France.
Introduction: Long-term post-liver transplant (LTx) complications, particularly impaired renal function (RF) and its consequences, remain a concern. Presented here are the results of the SIMCER…
2016 American Transplant Congress
The Importance of KDPI in Simultaneous Liver and Kidney Transplant.
E. Chan,¹ M. Hertl,¹ J. Perkins.²
¹General Surgery, Rush University Medical Center, Chicago, IL; ²Surgery, University of Washington, Seattle, WA.
Background: The use of the Donor Risk Index (DRI) in liver transplantation and the Kidney Donor Profile Index (KDPI) in kidney transplantation has been well…
2016 American Transplant Congress
Short-Term Post-Donation Renal Function in Living Kidney Donors.
L. Fahmy, A. Massie, A. Muzaale, S. Sandal, E. Chow, D. Segev.
JHU, Baltimore.
Previous single-center studies of post-donation estimated glomerular filtration rate (eGFR) in living kidney donors were limited by small sample size and lack of generalizability. The…